Pfizer’s $6.49 Billion Prevnar Franchise Faces a New Challenger
Pfizer’s $6.49 Billion Prevnar Franchise Faces a New Challenger TIKR.com
Covered in this story
Analyst targets on Pfizer
- BMO Capital Markets: $27.3 → $30 by Aug 2027 · Buy via 富途牛牛
- HSBC: $23.7 → $28 by Jul 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PFE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Pfizer →Dalsna Finance is currently tracking 47 stories mentioning Pfizer, the earliest published 18 Jun 2026.
Summary aggregated from TIKR.com's public RSS feed. The full reporting belongs to TIKR.com — please read it on their site.